Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16046408 | 0.88 | ELANE (0.56) | ELANESRCTGFBR1TP53GAA | |
| SCHEMBL30677933 | 0.88 | ELANE (0.56) | ELANESRCTGFBR1TP53GAA | |
| SCHEMBL14322808 | 0.87 | ELANE (0.53) | ELANEPTGS2MAPTMAPK1KMT2A | |
| SCHEMBL2456259 | 0.80 | ELANE (0.56) | ELANEPTGS2MAPTKMT2A | |
| SCHEMBL2455045 | 0.78 | PTGS2 (0.52) | PTGS2MAPTHTT | |
| SCHEMBL18928202 | 0.78 | MAPT (0.59) | ELANEPTGS2SRCTGFBR1TP53 | |
| SCHEMBL9915764 | 0.76 | ELANE (0.54) | ELANEPTGS2GAAMAPTNPC1 | |
| SCHEMBL2609807 | 0.76 | ELANE (0.54) | ELANEPTGS2GAAMAPTNPC1 | |
| SCHEMBL10085730 | 0.76 | ELANE (0.54) | ELANEPTGS2MAPTNPC1KMT2A | |
| SCHEMBL17427341 | 0.76 | ELANE (0.54) | ELANEPTGS2GAAMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9176257-B2 | Conjugated aromatic compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | disclosed |
| US-9176257-B2 | Conjugated aromatic compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | disclosed |
| US-9176257-B2 | Conjugated aromatic compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20120330052-A1 | CONJUGATED AROMATIC COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2012-12-27 | — | — | US | disclosed |
| US-20120330052-A1 | CONJUGATED AROMATIC COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2012-12-27 | — | — | US | disclosed |
| US-20120330052-A1 | CONJUGATED AROMATIC COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2012-12-27 | — | — | US | disclosed |
| WO-2011118541-A1 | CONJUGATED AROMATIC COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120330052-A1 | CONJUGATED AROMATIC COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | AHR, AXIN2, NR2E3 | ELANE 4469/4885PTGS2 4401/4885SRC 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.